431 related articles for article (PubMed ID: 3926613)
21. [The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol].
Sthler-Klich HM; Hopf R; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 2():179-82; discussion 188-9. PubMed ID: 2686258
[TBL] [Abstract][Full Text] [Related]
22. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
23. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
Rao YV; Reddy KS; Wasir HS
Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
[TBL] [Abstract][Full Text] [Related]
24. Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?
Romano M; Di Maro T; Carella G; Cotecchia MR; Caiazzo MR; de Arcangelis E; Chiariello M; Condorelli M
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):468-70. PubMed ID: 3198303
[TBL] [Abstract][Full Text] [Related]
25. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
[TBL] [Abstract][Full Text] [Related]
26. Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
Lai C; Onnis E; Pirisi R; Orani E; Delogu G; Cherchi A
Drugs Exp Clin Res; 1988; 14(11):699-705. PubMed ID: 3073077
[TBL] [Abstract][Full Text] [Related]
27. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
28. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
Silber S; Vogler A; Theisen K
Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
[TBL] [Abstract][Full Text] [Related]
29. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
Rudolph W; Blasini R; Reiniger G; Brügmann U
Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
[TBL] [Abstract][Full Text] [Related]
30. Randomized placebo-controlled comparative study of nifedipine, verapamil and isosorbide dinitrate in the treatment of angina at rest.
Rizzon P; Scrutinio D; Mangini SG; Lagioia R; de Toma L
Eur Heart J; 1986 Jan; 7(1):67-76. PubMed ID: 3514224
[TBL] [Abstract][Full Text] [Related]
31. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Dorow P; Schiess W
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
[TBL] [Abstract][Full Text] [Related]
32. [Anti-ischemic effect of 8 mg molsidomin in retard form].
Blasini R; Brügmann U; Rudolph W
Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
Weidemann H; Schuon J; Schober B
Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
[TBL] [Abstract][Full Text] [Related]
34. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
35. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
Rettig GF; Jakob M; Koch HP
Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
[TBL] [Abstract][Full Text] [Related]
36. Induction and circumvention of nitrate tolerance applying different dosage intervals.
Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of isosorbide dinitrate and nifedipine in the treatment of variant angina pectoris. Randomized study].
Aschermann M; Bultas J; Karetová D; Kölbel F; Simper D; Kozáková M
Cas Lek Cesk; 1989 Sep; 128(37):1178-81. PubMed ID: 2805034
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Akhras F; Jackson G
Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
